Molecular Docking: Methodological Approaches of Risk Assessment
Introduction. Computational chemistry methods and, particularly, the noncovalent molecular docking are increasingly implemented into the practice of drug development. Previously, a risk management of potential biases did not applied for this relatively young research instrument.Aim. The study object...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
LLC Center of Pharmaceutical Analytics (LLC «CPHA»)
2023-05-01
|
| Series: | Разработка и регистрация лекарственных средств |
| Subjects: | |
| Online Access: | https://www.pharmjournal.ru/jour/article/view/1501 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850047131034845184 |
|---|---|
| author | A. Kh. Taldaev I. D. Nikitin R. P. Terekhov I. A. Selivanova |
| author_facet | A. Kh. Taldaev I. D. Nikitin R. P. Terekhov I. A. Selivanova |
| author_sort | A. Kh. Taldaev |
| collection | DOAJ |
| description | Introduction. Computational chemistry methods and, particularly, the noncovalent molecular docking are increasingly implemented into the practice of drug development. Previously, a risk management of potential biases did not applied for this relatively young research instrument.Aim. The study objective was to design the risk assessment system for noncovalent molecular docking.Materials and methods. The development of bias risk assessment system was based on the world's leading practices in noncovalent molecular docking.Results and discussions. As a result of the deductive analysis of the molecular docking process, bias domains were identified and a risk-based algorithm was proposed, which was tested on a sample of articles obtained during a systematic review. A tendency to frequent limited provision of information on the methodology of the computational experiment, as well as on the application of practices proven to lead to irrelevant results of molecular docking, has been revealed.Conclusion. The data obtained cannot be extrapolated to all studies that refer to the results of molecular modeling. However, through the proposed risk-based algorithm, the attention of researchers is focused on assessing the quality of such publications. We hope that the developed tool for bias risk assessment in noncovalent molecular docking will be finalized and eventually put into practice. It will possibly reduce the share of low-quality work in the field of drug development at the earliest stages. |
| format | Article |
| id | doaj-art-195f052d6c4e464698ccd963c6c41158 |
| institution | DOAJ |
| issn | 2305-2066 2658-5049 |
| language | Russian |
| publishDate | 2023-05-01 |
| publisher | LLC Center of Pharmaceutical Analytics (LLC «CPHA») |
| record_format | Article |
| series | Разработка и регистрация лекарственных средств |
| spelling | doaj-art-195f052d6c4e464698ccd963c6c411582025-08-20T02:54:16ZrusLLC Center of Pharmaceutical Analytics (LLC «CPHA»)Разработка и регистрация лекарственных средств2305-20662658-50492023-05-0112220621010.33380/2305-2066-2023-12-2-206-2101114Molecular Docking: Methodological Approaches of Risk AssessmentA. Kh. Taldaev0I. D. Nikitin1R. P. Terekhov2I. A. Selivanova3Institute of Biomedical Chemistry named after V. N. Orekhovich; A. P. Nelyubin Institute of Pharmacy, I. M. Sechenov First MSMU of the Ministry of Health of the Russian Federation (Sechenov University)A. P. Nelyubin Institute of Pharmacy, I. M. Sechenov First MSMU of the Ministry of Health of the Russian Federation (Sechenov University)A. P. Nelyubin Institute of Pharmacy, I. M. Sechenov First MSMU of the Ministry of Health of the Russian Federation (Sechenov University)A. P. Nelyubin Institute of Pharmacy, I. M. Sechenov First MSMU of the Ministry of Health of the Russian Federation (Sechenov University)Introduction. Computational chemistry methods and, particularly, the noncovalent molecular docking are increasingly implemented into the practice of drug development. Previously, a risk management of potential biases did not applied for this relatively young research instrument.Aim. The study objective was to design the risk assessment system for noncovalent molecular docking.Materials and methods. The development of bias risk assessment system was based on the world's leading practices in noncovalent molecular docking.Results and discussions. As a result of the deductive analysis of the molecular docking process, bias domains were identified and a risk-based algorithm was proposed, which was tested on a sample of articles obtained during a systematic review. A tendency to frequent limited provision of information on the methodology of the computational experiment, as well as on the application of practices proven to lead to irrelevant results of molecular docking, has been revealed.Conclusion. The data obtained cannot be extrapolated to all studies that refer to the results of molecular modeling. However, through the proposed risk-based algorithm, the attention of researchers is focused on assessing the quality of such publications. We hope that the developed tool for bias risk assessment in noncovalent molecular docking will be finalized and eventually put into practice. It will possibly reduce the share of low-quality work in the field of drug development at the earliest stages.https://www.pharmjournal.ru/jour/article/view/1501molecular dockingdrug developmentmolecular modelingvirtual screeningrisk assessment |
| spellingShingle | A. Kh. Taldaev I. D. Nikitin R. P. Terekhov I. A. Selivanova Molecular Docking: Methodological Approaches of Risk Assessment Разработка и регистрация лекарственных средств molecular docking drug development molecular modeling virtual screening risk assessment |
| title | Molecular Docking: Methodological Approaches of Risk Assessment |
| title_full | Molecular Docking: Methodological Approaches of Risk Assessment |
| title_fullStr | Molecular Docking: Methodological Approaches of Risk Assessment |
| title_full_unstemmed | Molecular Docking: Methodological Approaches of Risk Assessment |
| title_short | Molecular Docking: Methodological Approaches of Risk Assessment |
| title_sort | molecular docking methodological approaches of risk assessment |
| topic | molecular docking drug development molecular modeling virtual screening risk assessment |
| url | https://www.pharmjournal.ru/jour/article/view/1501 |
| work_keys_str_mv | AT akhtaldaev moleculardockingmethodologicalapproachesofriskassessment AT idnikitin moleculardockingmethodologicalapproachesofriskassessment AT rpterekhov moleculardockingmethodologicalapproachesofriskassessment AT iaselivanova moleculardockingmethodologicalapproachesofriskassessment |